bn:03191867n
Noun Named Entity
Categories: 2006 in London, Abandoned drugs, Drugs that are a monoclonal antibody, Monoclonal antibodies, Articles without InChI source
EN
theralizumab  Anti-CD28 SuperMAB  CD28-SuperMAB  TAB08  Te genero
EN
Theralizumab is an immunomodulatory drug developed by Thomas Hünig of the University of Würzburg. Wikipedia
Definitions
Relations
Sources
EN
Theralizumab is an immunomodulatory drug developed by Thomas Hünig of the University of Würzburg. Wikipedia
Wikipedia
Wikidata
Wikidata Alias